期刊
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
卷 19, 期 11, 页码 -出版社
SPRINGER
DOI: 10.1007/s11910-019-1006-z
关键词
Parkinson's disease; Alzheimer's disease; Gray matter atrophy; Cognition; Structural magnetic resonance imaging
资金
- European Union [734718]
- Ministry of Health, Czech Republic [AZV 16-31868A]
- European Regional Development Fund Project National infrastructure for biological and medical imaging [CZ.02. 1.01/0.0/0.0/16 013/0001775]
Purpose of Review We summarize structural (s)MRI findings of gray matter (GM) atrophy related to cognitive impairment in Alzheimer's disease (AD) and Parkinson's disease (PD) in light of new analytical approaches and recent longitudinal studies results. Recent Findings The hippocampus-to-cortex ratio seems to be the best sMRI biomarker to discriminate between various AD subtypes, following the spatial distribution of tau pathology, and predict rate of cognitive decline. PD is clinically far more variable than AD, with heterogeneous underlying brain pathology. Novel multivariate approaches have been used to describe patterns of early subcortical and cortical changes that relate to more malignant courses of PD. New emerging analytical approaches that combine structural MRI data with clinical and other biomarker outcomes hold promise for detecting specific GM changes in the early stages of PD and preclinical AD that may predict mild cognitive impairment and dementia conversion.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据